XML 70 R33.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Convertible Preferred Stock

At December 31, 2024, the Company’s convertible preferred stock consisted of the following (in thousands, except share and per share amounts):

Series

 

Shares
Authorized

 

 

Shares
Outstanding

 

 

Per Share
Original
Issuance and
Conversion
Price

 

 

Liquidation
Preference

 

 

Carrying
Value

 

Series A

 

 

26,250,131

 

 

 

26,250,131

 

 

$

0.5714

 

 

$

15,000

 

 

$

14,850

 

Series B

 

 

22,660,592

 

 

 

22,660,592

 

 

$

1.2857

 

 

 

29,135

 

 

 

29,054

 

Series C

 

 

48,030,730

 

 

 

48,030,730

 

 

$

1.7697

 

 

 

85,000

 

 

 

82,852

 

Total

 

 

96,941,453

 

 

 

96,941,453

 

 

 

 

 

$

129,135

 

 

$

126,756

 

Schedule of Weighted-average Assumptions Used to Determine Fair Value of Stock Options Granted

The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the stock options granted in the years ended December 31, 2025 and 2024 were as follows:

 

 

 

Year Ended
December 31,

 

 

 

2025

 

 

2024

 

Risk-free interest rate

 

 

4.09

%

 

 

4.05

%

Expected volatility

 

 

103.3

%

 

 

101.7

%

Expected term (in years)

 

 

6.0

 

 

 

6.0

 

Expected dividend yield

 

 

 

 

 

 

Schedule of Allocation of Stock Based Compensation Expense

The allocation of stock-based compensation expense was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

Research and development expense

 

$

1,731

 

 

$

288

 

General and administrative expense

 

 

2,217

 

 

 

151

 

Total stock-based compensation expense

 

$

3,948

 

 

$

439

 

Schedule of Early Exercise of Stock Option Awards

A summary of the unvested common stock issued pursuant to an early exercise of stock option awards is as follows:

 

 

 

Number of
Unvested
Shares

 

Balance at January 1, 2025

 

 

8,417

 

Early-exercised stock options

 

 

2,950

 

Vested shares

 

 

(11,367

)

Balance at December 31, 2025

 

 

 

Schedule of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following:

 

 

 

December 31,

 

 

 

2025

 

 

2024

 

Conversion of outstanding convertible preferred stock

 

 

 

 

 

11,439,841

 

Outstanding stock options

 

 

3,038,413

 

 

 

991,058

 

Shares available for issuance under the Plans

 

 

849,328

 

 

 

1,164,562

 

Shares available for issuance under the ESPP

 

 

185,408

 

 

 

 

Total

 

 

4,073,149

 

 

 

13,595,461

 

Employee and Non-Employee Awards  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

Stock option activity for employee and nonemployee awards and related information is as follows:

 

 

 

Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding and expected to vest at December 31, 2024

 

 

991,058

 

 

$

3.83

 

 

 

8.4

 

 

$

3,175

 

Granted

 

 

2,315,283

 

 

$

10.81

 

 

 

 

 

 

 

Exercised

 

 

(149,876

)

 

$

2.43

 

 

 

 

 

 

 

Canceled/forfeited

 

 

(118,052

)

 

$

7.44

 

 

 

 

 

 

 

Outstanding and expected to vest at December 31, 2025

 

 

3,038,413

 

 

$

9.08

 

 

 

9.0

 

 

$

12,360

 

Exercisable at December 31, 2025

 

 

374,682

 

 

$

3.44

 

 

 

6.9

 

 

$

3,627